Balaxi Pharma Share Price
Balaxi Pharma Share Price Today
As of 17 Aug 2026, Balaxi Pharma share price is ₹24.01. The stock opened at ₹23.60, compared to its previous close of ₹23.99. During today's trading session, Balaxi Pharma share price moved in the range of ₹23.53 to ₹24.23, with an average price of ₹23.88 for the day. Looking at its last 52-week, the stock has touched a low of ₹15.20 and a high of ₹49.65. On the performance front, Balaxi Pharma share price has increased by 9.89% over the last six months and is down 49.70% on a year-on-year basis.
Balaxi Pharma Returns Calculator
About Balaxi Pharma
Balaxi Pharmaceuticals Limited is an India-based company. The Company operates as an intellectual property right (IPR)-based pharmaceutical company. The Company primarily operates in frontier markets across the Americas, Africa and the Caribbean islands. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It is engaged in International Wholesale Distribution of Pharmaceuticals. The Company’s products include Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents, and Laxative. Its Boadent brand includes anticavity dental toothpaste. Its subsidiaries are Balaxi Global DMCC, Dubai and Balaxi healthcare Ecuador.
Balaxi Pharma Financial Highlights
- Revenue: Balaxi Pharma reported revenue of ₹272.99 crore in FY26 vs ₹288.84 crore in FY25. It showed a decrease of 5.49% on a yearly basis.
- Operating Profit: Balaxi Pharma reported an operating profit of ₹5.29 crore in FY26 vs ₹28.67 crore in FY25. It showed a decrease of 81.55% on a year-on-year basis.
- Net Profit: Balaxi Pharma reported a net profit of ₹1.42 crore in FY26 vs ₹25.07 crore in FY25. It showed a decrease of 94.34% on a yearly basis.
Balaxi Pharma Quarterly Result Highlights
- Balaxi Pharma reported revenue of ₹79.69 crore in Jun 2026, compared with ₹73.63 crore in Mar 2026, representing an increase of 8.23% on a quarter-on-quarter (QoQ) basis.
- Balaxi Pharma reported an operating profit of ₹2.09 crore in Jun 2026, compared with ₹1.40 crore in Mar 2026, representing an increase of 49.29% on a quarter-on-quarter (QoQ) basis.
- Balaxi Pharma reported a profit of ₹1.30 crore in Jun 2026, compared with ₹0.61 crore in Mar 2026, reflecting an increase of 113.11% on a QoQ basis.
- The earnings per share (EPS) of Balaxi Pharma stood at ₹4.54 during Jun 2026.
| Sep 2025 | 3.50% |
|---|---|
| Dec 2025 | 1.74% |
| Mar 2026 | 0.00% |
| Jun 2026 | 0.00% |
Balaxi Pharma Shareholder Returns
Balaxi Pharma Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,61,848.00 | 38.12 | 5.53 | 13.74% | 0.61 | 17.33% | 93.24 | 0.83% | 0.48 | 10.90 |
| Divis Laboratories | 2,25,648.00 | 77.15 | 13.46 | 15.32% | 0.00 | 19.56% | 629.49 | 0.35% | 0.55 | 98.19 |
| Torrent Pharmaceuticals | 1,84,109.00 | 85.40 | 21.89 | 25.49% | 1.69 | 13.85% | 222.76 | 0.70% | 0.49 | 58.70 |
| Cipla | 1,17,139.00 | 34.91 | 3.40 | 11.27% | 0.00 | 14.95% | 423.36 | 0.90% | 0.45 | 43.52 |
| Zydus Lifesciences | 1,13,715.00 | 24.76 | 4.19 | 18.59% | 0.31 | 17.35% | 237.30 | 0.09% | 0.33 | 35.38 |
| Lupin | 1,02,191.00 | 18.41 | 4.55 | 23.76% | 0.04 | 24.88% | 659.05 | 0.81% | 0.57 | 129.18 |
| Dr. Reddy's Laboratories | 1,00,328.00 | 31.52 | 2.64 | 11.07% | 0.18 | 12.54% | 377.96 | 0.67% | 0.41 | 38.68 |
| Mankind Pharma | 99,945.00 | 48.34 | 6.13 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.44 | 49.37 |
| Laurus Labs | 98,064.00 | 89.94 | 18.50 | 16.77% | 0.40 | 16.14% | 97.20 | 0.11% | 0.67 | 13.72 |
| Aurobindo Pharma | 96,296.90 | 25.95 | 2.54 | 9.25% | 0.19 | 11.76% | 391.14 | 0.24% | 0.38 | 41.58 |
Balaxi Pharma Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹292.56 | ₹241.29 | ₹336.43 | ₹279.39 |
| Other Income | ₹2.36 | ₹0.63 | ₹2.64 | ₹4.97 |
| Total Revenue | ₹294.92 | ₹241.93 | ₹339.07 | ₹284.36 |
| Total Expenses | ₹266.25 | ₹201.62 | ₹282.15 | ₹229.84 |
| Profit Before Tax | ₹28.67 | ₹2.02 | ₹56.92 | ₹54.52 |
| Tax | ₹3.60 | ₹4.40 | ₹10.96 | ₹6.86 |
| Profit After Tax | ₹25.07 | -₹2.39 | ₹45.96 | ₹47.66 |
| EPS - Basic | ₹4.54 | -₹0.46 | ₹45.81 | ₹47.66 |
| EPS - Diluted | ₹4.54 | -₹0.46 | ₹45.40 | ₹47.66 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹28.67 | ₹2.02 | ₹56.92 | ₹54.52 |
| Income before WC changes | ₹36.10 | ₹0.87 | ₹64.96 | ₹55.70 |
| Change in Assets | -₹55.02 | ₹14.35 | -₹31.74 | -₹43.32 |
| Change in Liabilities | -₹12.87 | -₹3.67 | -₹15.05 | ₹27.36 |
| Change in WC | -₹67.89 | ₹10.68 | -₹46.79 | -₹15.97 |
| Cash flow from Operations | -₹35.00 | ₹4.87 | ₹6.08 | ₹34.14 |
| Cash flow from Investing | -₹21.76 | -₹1.05 | -₹10.57 | -₹28.45 |
| Cash flow from Financing | ₹33.88 | ₹30.25 | ₹25.51 | -₹0.16 |
| Total Cash Flow | -₹22.89 | ₹34.07 | ₹21.02 | ₹5.53 |
| Cash (Start of the year) | ₹62.29 | ₹28.21 | ₹7.19 | ₹1.66 |
| Cash (End of the year) | ₹39.40 | ₹62.29 | ₹28.21 | ₹7.19 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹67.58 | ₹48.17 | ₹46.16 | ₹35.47 |
| Current Assets | ₹242.77 | ₹210.17 | ₹193.51 | ₹141.00 |
| Total Assets | ₹310.34 | ₹258.34 | ₹239.67 | ₹176.47 |
| Current Liabilities | ₹54.53 | ₹54.20 | ₹53.13 | ₹63.27 |
| Net Current Asset | ₹188.23 | ₹155.97 | ₹140.38 | ₹77.74 |
| Non-Current Liabilities | ₹24.07 | ₹2.78 | ₹3.66 | ₹0.04 |
| Equity Capital | ₹231.74 | ₹201.36 | ₹182.88 | ₹113.16 |
| Total Equity & Liabilities | ₹310.34 | ₹258.34 | ₹239.67 | ₹176.47 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹60.99 | ₹70.20 | ₹108.14 | ₹101.29 |
| Other Income | ₹5.37 | ₹2.40 | ₹6.60 | ₹2.75 |
| Total Revenue | ₹66.36 | ₹72.59 | ₹114.74 | ₹104.04 |
| Total Expenses | ₹61.07 | ₹67.01 | ₹92.29 | ₹84.34 |
| Profit Before Tax | ₹5.29 | ₹5.58 | ₹22.45 | ₹19.70 |
| Tax | ₹1.69 | ₹1.93 | ₹6.23 | ₹5.03 |
| Profit After Tax | ₹3.60 | ₹3.65 | ₹16.22 | ₹14.67 |
| EPS - Basic | ₹0.65 | ₹0.71 | ₹16.17 | ₹14.67 |
| EPS - Diluted | ₹0.65 | ₹0.71 | ₹16.02 | ₹14.67 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹5.29 | ₹5.58 | ₹22.45 | ₹19.70 |
| Income before WC changes | ₹7.80 | ₹7.63 | ₹23.43 | ₹20.01 |
| Change in Assets | -₹10.93 | ₹0.57 | -₹27.37 | -₹6.00 |
| Change in Liabilities | -₹2.84 | -₹4.96 | ₹2.29 | ₹0.56 |
| Change in WC | -₹13.77 | -₹4.39 | -₹25.08 | -₹5.44 |
| Cash flow from Operations | -₹7.60 | -₹1.83 | -₹7.07 | ₹8.89 |
| Cash flow from Investing | -₹24.98 | ₹0.46 | -₹2.29 | -₹6.87 |
| Cash flow from Financing | ₹17.21 | ₹27.55 | ₹26.39 | -₹1.64 |
| Total Cash Flow | -₹15.37 | ₹26.19 | ₹17.03 | ₹0.38 |
| Cash (Start of the year) | ₹44.06 | ₹17.87 | ₹0.84 | ₹0.47 |
| Cash (End of the year) | ₹28.68 | ₹44.06 | ₹17.88 | ₹0.84 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹54.84 | ₹31.46 | ₹30.70 | ₹27.84 |
| Current Assets | ₹119.60 | ₹122.90 | ₹99.02 | ₹54.08 |
| Total Assets | ₹174.45 | ₹154.36 | ₹129.72 | ₹81.92 |
| Current Liabilities | ₹43.76 | ₹30.04 | ₹34.83 | ₹23.97 |
| Net Current Asset | ₹75.84 | ₹92.86 | ₹64.19 | ₹30.11 |
| Non-Current Liabilities | ₹2.83 | ₹2.78 | ₹2.79 | ₹0.04 |
| Equity Capital | ₹127.85 | ₹121.55 | ₹92.11 | ₹57.91 |
| Total Equity & Liabilities | ₹174.45 | ₹154.36 | ₹129.72 | ₹81.92 |
| 14 Aug | 0L |
|---|---|
| 13 Aug | 0L |
| 12 Aug | 0L |
| 11 Aug | 0L |
| 10 Aug | 0L |
| Average | 0L |
Popular Stocks
Balaxi Pharma Share Price FAQs
What is Balaxi Pharma share price today?
Balaxi Pharma share price is ₹24.01 as on 14 Aug, 2026, 15:26 IST.
How has the Balaxi Pharma share price performed in the past?
In the last 1 year, Balaxi Pharma delivered a return of -49.70%. The Balaxi Pharma share price hit a high of ₹49.65 and low of ₹15.20.
How much is the Mutual Fund shareholding in Balaxi Pharma shares?
The Mutual Fund Shareholding in Balaxi Pharma was 0.00% at the end of Jun 2026.
What is the the 52-week high and low of Balaxi Pharma shares ?
The 52-week high and low of Balaxi Pharma share is ₹49.65 and ₹15.20 as of 14 Aug, 2026.
What is the market cap of Balaxi Pharma?
The market capitalisation of Balaxi Pharma is ₹132.50 Crores as on 14 Aug, 2026.
What are the stock symbols of Balaxi Pharma?
The stock symbol of Balaxi Pharma is BALAXI on the NSE, , and the ISIN is INE618N01022.
What was yesterday's closing price for Balaxi Pharma shares ?
Balaxi Pharma shares closed yesterday at ₹23.99 on NSE
How to buy Balaxi Pharma shares?
To buy Balaxi Pharma shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Balaxi Pharma shares on Holidays?
No, shares of Balaxi Pharma or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Balaxi Pharma shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Balaxi Pharma?
The PE and PB ratio of Balaxi Pharma is 54.55 and 0.53 respectively, as on 14 Aug, 2026, 15:26 IST.
